Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Completed- Nanofluidic immunoassays to replace ELISA tests: Diflusel

This project aims to use new effects at the nanoscale to develop a universal device to selectively preconcentrate any molecules of interest by a factor of 1000 in just a few minutes.

This technology appears to be vastly more efficient than current ELISA immunoassays.

 

This project is completed now. If interested, feel free to contact us. 

A nanofluidic system designed to replace ELISA immunoassays: introduction

An immunoassay is a biochemical test that detects and quantifies a particular analyte in a sample based on its ability to act as an antigen. 

Enzyme-linked immunosorbent assays (ELISA) rely on an antibody’s innate capacity to bind to a molecule’s unique structure.

The Diflusel project aims to design and study a novel immunoassay device based on a new method of selective electro-preconcentration with fluidic chips bearing a nanochannel.

Academic research and published results have already demonstrated that preconcentration regimes could be controlled by introducing a nanochannel in fluidic chips.

However, the location of the preconcentration strongly depends on the mobility of the analyte under the electric field.

Diflusel Nanofluidic electro-concentration-designed to replace elisa assay

A nanofluidic system designed to replace ELISA immunoassays: project description

To obtain selectivity, we propose a novel preconcentration methodology in this project that uses additional hydrodynamic pressure to ideally monitor the competition between electrophoretic and electro-osmotic flows. This new electro-preconcentration method enables an exact adjustment of the location of the different pre-concentrated analytes.

Selectivity is reached because the preconcentration and separation of the analytes are obtained in one single step.


Since these micro-nanofluidic devices offer a fast preconcentration time of around one minute, this new methodology is a real breakthrough compared to conventional ELISA immunoassays.

Our recent experimental results confirm that this additional pressure significantly improves the preconcentration rate. The purpose of the DIFLUSEL project will be to demonstrate that the limit of detection (LOD) can be 100 times lower than the LOD of conventional immunoassays. Thus, pathogenic analytes at deficient concentrations in the femtomolar regime should be detected based on this new methodology.

This project will have critical practical applications for defense and civil applications, such as medical diagnostics.

This project is ongoing through a partnership between the Microfluidics Innovation Center and an academic group specialized in nanofluidics (LPN CNRS).

This project was funded by the French National Research Agency (Agence Nationale de la Recherche, ANR) under the No ANR13-ASTR-0035 (Diflusel).

ANR_Logo_microfluidics innovation center

Check our Projects